Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
113.47B | 103.72B | 97.38B | 94.45B | 118.44B | Gross Profit |
29.11B | 24.48B | 21.96B | 24.00B | 50.26B | EBIT |
7.45B | 3.78B | 1.61B | 4.12B | 4.18B | EBITDA |
13.11B | 9.26B | 6.45B | 9.24B | 8.98B | Net Income Common Stockholders |
5.57B | 3.07B | 1.10B | 3.37B | 3.17B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
17.39B | 19.59B | 16.18B | 16.79B | 14.79B | Total Assets |
95.84B | 94.23B | 87.63B | 83.26B | 78.87B | Total Debt |
3.69B | 5.34B | 5.75B | 1.07B | 1.36B | Net Debt |
-13.71B | -14.23B | -10.43B | -15.72B | -13.43B | Total Liabilities |
34.34B | 37.80B | 34.09B | 30.48B | 28.31B | Stockholders Equity |
61.49B | 56.43B | 53.54B | 52.79B | 50.56B |
Cash Flow | Free Cash Flow | |||
-294.00M | 4.46B | -3.60B | 3.18B | 2.29B | Operating Cash Flow |
6.53B | 9.81B | 2.12B | 8.09B | 8.05B | Investing Cash Flow |
-6.47B | -5.29B | -6.74B | -5.12B | -5.63B | Financing Cash Flow |
-2.23B | -1.18B | 3.97B | -1.08B | -932.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥65.45B | 18.87 | 2.61% | 11.18% | 28.19% | ||
76 Outperform | ¥64.05B | 11.53 | 0.38% | 9.41% | 80.83% | ||
72 Outperform | ¥34.39B | 10.60 | 0.84% | 13.43% | 60.07% | ||
69 Neutral | ¥31.61B | 14.35 | 1.28% | 6.01% | 14.07% | ||
65 Neutral | $8.88B | 15.01 | 4.67% | 6.15% | 3.61% | -2.60% | |
62 Neutral | ¥60.39B | 37.23 | 1.28% | 3.75% | 44.95% | ||
59 Neutral | ¥33.80B | 27.44 | 1.79% | 0.62% | -32.02% |